scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1034276845 |
P356 | DOI | 10.1186/SCRT228 |
P932 | PMC publication ID | 3854709 |
P698 | PubMed publication ID | 23826999 |
P5875 | ResearchGate publication ID | 245536838 |
P2093 | author name string | Sin-Soo Jeun | |
Yun Hou | |||
Chang Hyun Jeong | |||
Chung Heon Ryu | |||
Seong Muk Kim | |||
Kwang Ywel Park | |||
P2860 | cites work | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia | Q28199417 | ||
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease | Q28207482 | ||
Minocycline-induced autoimmune syndromes: an overview | Q28369204 | ||
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII | Q28576309 | ||
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins | Q29547534 | ||
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
Mesenchymal stem cells: biology and potential clinical uses | Q34034011 | ||
Inhibition of autoimmune encephalomyelitis by a tetracycline. | Q34113359 | ||
Mesenchymal stem cells for the treatment of neurodegenerative disease. | Q34473474 | ||
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. | Q34514721 | ||
Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation | Q34604586 | ||
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease | Q35057231 | ||
Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis | Q35624714 | ||
The promise of minocycline in neurology. | Q35958974 | ||
Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. | Q36547021 | ||
Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. | Q37020018 | ||
Remyelination of the spinal cord following intravenous delivery of bone marrow cells | Q37020042 | ||
Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis | Q37084467 | ||
Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis | Q37139712 | ||
Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. | Q37253314 | ||
Combined treatment with atorvastatin and minocycline suppresses severity of EAE. | Q40113108 | ||
Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis. | Q40166791 | ||
Effects of minocycline and doxycycline on cell survival and gene expression in human gingival and periodontal ligament cells | Q40311936 | ||
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 | ||
CD4+ T-cell subsets in autoimmunity | Q41716697 | ||
Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice | Q43031797 | ||
Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord | Q43188431 | ||
Chemotactic and cytotoxic effects of minocycline on human retinal pigment epithelial cells | Q43216670 | ||
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis | Q44002202 | ||
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. | Q44880234 | ||
Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice | Q46499204 | ||
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis | Q46548808 | ||
Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | Q48497239 | ||
Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. | Q50632074 | ||
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis | Q57080081 | ||
Minocycline and Lupuslike Syndrome in Acne Patients | Q57945128 | ||
Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation | Q73008879 | ||
Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis | Q80124972 | ||
P433 | issue | 4 | |
P921 | main subject | minocycline | Q415336 |
experimental autoimmune encephalomyelitis | Q494066 | ||
bone marrow | Q546523 | ||
P304 | page(s) | 77 | |
P577 | publication date | 2013-07-05 | |
P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
P1476 | title | Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice | |
P478 | volume | 4 |
Q37635109 | Amelioration of experimental autoimmune encephalomyelitis through transplantation of placental derived mesenchymal stem cells |
Q58571948 | Combination therapy of human bone marrow-derived mesenchymal stem cells and minocycline improves neuronal function in a rat middle cerebral artery occlusion model |
Q29994669 | Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy |
Q53608103 | Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis. |
Q33922806 | Minocycline modulates NFκB phosphorylation and enhances antimicrobial activity against Staphylococcus aureus in mesenchymal stromal/stem cells |
Q89819969 | Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome |
Q47135235 | Practical considerations for choosing a mouse model of Alzheimer's disease |
Q40757812 | Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis |
Q42738285 | Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice |
Q57538743 | The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review |
Q48922248 | The beneficial effect of encapsulated human adipose-derived stem cells in alginate hydrogel on neural differentiation. |
Search more.